Text Messages for Liver Transplant Recipients
Text Messages for Adolescent and Young Adult Liver Transplant Recipients
1 other identifier
interventional
35
1 country
1
Brief Summary
Although medical advancements have enabled children experiencing liver transplants to live longer, medical management post-transplant is ongoing and complex. Many findings underscore adolescents as being a particularly vulnerable population, with rates of nonadherence being four times higher than in adults. This pilot study aims to explore the feasibility and impact of a brief text-messaging intervention in a randomized controlled trials (N = 50). We have three primary aims: 1) Study patient satisfaction with and utilization of this intervention in order to better understand feasibility and acceptability; 2) Investigate the effects of this intervention on medication adherence, healthcare utilization, and health status; and 3) Examine potential effects of the intervention on the physician-patient relationship, motivation for adherence, and other variables.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Aug 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 26, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
December 26, 2020
CompletedFirst Submitted
Initial submission to the registry
July 30, 2021
CompletedFirst Posted
Study publicly available on registry
August 9, 2021
CompletedAugust 23, 2021
August 1, 2021
1.4 years
July 30, 2021
August 17, 2021
Conditions
Outcome Measures
Primary Outcomes (2)
Self-Reported Medication Adherence
Visual Analogue Scale (0-100% range, with higher scores indicating better values)
9 months
Medication Variability Observed in Immunosuppressant Labs
medication level variability index (calculated as standard deviation of at least 3 lab values, with lower scores indicating better values)
12 months
Secondary Outcomes (1)
Motivation for Adherence
9 months
Study Arms (2)
Praise Text Messages
EXPERIMENTALThe text message praise intervention lasted for 6 months. Each week, transplant coordinators, masked from who enrolled in the study or to which condition participants were randomized, prepared a list of all patients in the study age group whose laboratory blood tests indicated that immunosuppressant medications were within the expected range. A researcher reviewed the list to identify whether any of patients were currently assigned to the intervention, and if so, sent text message praise via REDCap's text message function. We rotated through 14 standardized text messages each week. Examples of messages included: "Your labs look very good. Super job taking your meds!" and "Your labs look great! Thanks for putting in the effort to take care of your health!."
Usual Care
NO INTERVENTIONParticipants in the usual care arm did not receive any praise text messages. All participants continued to receive usual care from the multidisciplinary liver transplant team, including phone calls and follow-up care when laboratory blood tests indicated that immunosuppressant medications were outside of the expected range.
Interventions
Texting messages with praise content, to positive reinforce medication adherence
Eligibility Criteria
You may qualify if:
- having a liver transplant
- receiving care at Children's Hospital Los Angeles
- having access to a working cellphone
- speaking English.
You may not qualify if:
- insufficient cognitive capacity to understand or engage in the procedures of the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Children's Hospital Los Angeles
Los Angeles, California, 90027, United States
Related Publications (3)
Walsh JC, Dalton M, Gazzard BG. Adherence to combination antiretroviral therapy assessed by anonymous patient self-report. AIDS. 1998 Dec 3;12(17):2361-3. No abstract available.
PMID: 9863888BACKGROUNDRollnick S, Miller WR, Butler C. Motivational interviewing in health care: helping patients change behavior. Guilford Press; 2008.
BACKGROUNDShemesh E, Fine RN. Is calculating the standard deviation of tacrolimus blood levels the new gold standard for evaluating non-adherence to medications in transplant recipients? Pediatr Transplant. 2010 Dec;14(8):940-3. doi: 10.1111/j.1399-3046.2010.01396.x. Epub 2010 Oct 1.
PMID: 20887400BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- CARE PROVIDER
- Masking Details
- Transplant coordinators were masked from intervention assignment
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor of Clinical Pediatrics
Study Record Dates
First Submitted
July 30, 2021
First Posted
August 9, 2021
Study Start
August 1, 2019
Primary Completion
December 26, 2020
Study Completion
December 26, 2020
Last Updated
August 23, 2021
Record last verified: 2021-08
Data Sharing
- IPD Sharing
- Will not share